Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people A population-based study / Iacopo Cancelli en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 654-659 Título : Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people A population-based study Tipo de documento: texto impreso Autores: Iacopo Cancelli, Autor ; Gian Luigi Gigli, Autor ; Antonella Piani, Autor Fecha de publicación: 2023 Artículo en la página: pp. 654-659 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antagonistas colinérgicos, Cognición - efectos de medicamentos, Trastornos cognitivos Resumen: Prevention of drug-related problems is a key issue in the aged. Anticholinergic (ACH) drugs are a biologically plausible and potentially modifiable risk factor for cognitive impairment. Therefore, we intended to evaluate the association between ACH drugs and cognitive impairment. Our study comprised 750 subjects aged 65 years or older. Cognitive impairment was evaluated using Mini-Mental State Examination and Global Deterioration Scale. Link: ./index.php?lvl=notice_display&id=30824 [artículo] Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people A population-based study [texto impreso] / Iacopo Cancelli, Autor ; Gian Luigi Gigli, Autor ; Antonella Piani, Autor . - 2023 . - pp. 654-659. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 654-659 Palabras clave: Antagonistas colinérgicos, Cognición - efectos de medicamentos, Trastornos cognitivos Resumen: Prevention of drug-related problems is a key issue in the aged. Anticholinergic (ACH) drugs are a biologically plausible and potentially modifiable risk factor for cognitive impairment. Therefore, we intended to evaluate the association between ACH drugs and cognitive impairment. Our study comprised 750 subjects aged 65 years or older. Cognitive impairment was evaluated using Mini-Mental State Examination and Global Deterioration Scale. Link: ./index.php?lvl=notice_display&id=30824

---

1 (1 - 1 / 1)